ABSTRACT
Background: Increasing introduction of innovation technologies into medicine and pharmacology makes it possible to modify and develop further the methods of the development of new medicines. Such methods include virtual screening. In this article approaches to building software for virtual screening of nitric oxide (NO)scavengers in an important class of azaheterocyclic compounds are discussed.Methods: During the study period (from October 2017 to January 2019) the methods for the evaluation of antioxidant activity, as well as quantum-mechanical and statistical calculations were conducted. Quantum-mechanical calculations on HOMO (highest occupied molecular orbital) energy and LUMO (lowest unoccupied molecular orbital) energy descriptors have been conducted using program complex WinMopac 7.2.Results: Evaluation methods of antioxidant activity, quantum-mechanical and statistical calculations have been presented. The algorithm for computer program of virtual screening has been proposed. Prospects and benefits of computer modeling of agent activity are considered.Conclusions: Establishment of computer program for virtual screening will significantly reduce time and resources during researching new synthesized compounds. The algorithm for a computer program of virtual screening has been developed Predictable antioxidant activity data on nitric oxide radical (NO·)inhibition may be calculated in percentage using HOMO and LUMO as the input data for this program.
ABSTRACT
Background: According to modern researches, endothelial dysfunction (ED) is one of the primary pathogenetic elements of cardiovascular diseases (myocardial infarction [MI], ischemic heart diseases, cerebral ischemic stroke, atherosclerosis, arterial hypertension, pulmonary hypertension, heart failure, and dilated cardiomyopathy) as well as obesity, hyperlipidemia, diabetes and hyperhomocysteinemia. The aim of this work was to study the infl uence of potential metabolitotropic cardioprotector “Angiolin” on the parameters of conjugate systems nitric oxide (NO)/restored thiols in heart under isadrine-pituitrin MI. Methods: This study was performed on Wistar white rats weighing 190-210 g. Biochemical, immune-enzyme analysis and histoimmunechemical study were performed. Results: In histological sections of hearts of the rats receiving Angiolin in parenteral dosing 50 mg/kg 30 mins before each pituitrin injection the density of endothelial NOsynthase (NOS)-positive cells increased by 29% and the density of inducible NOSpositive cells decreased by 23.3%. In cytosolic fraction of myocardium homogenate NOS activity increased by 27%, the concentration of NO stable metabolites increased by 70% and the content of nitrosative stress marker nitrotyrosine decreased by 42% when compared with control group. At the same time in similar samples of heart homogenate the increase of restored thiol groups’ level by 53.3%, methionine - by 35.1%, cysteine - by 170% and activity of glutathione reductase - by 186% was noted. The administration of reference drug mildronate to the animals with MI in dose 100 mg/kg did not result in signifi cant changes of the studied parameters of thiol-disulfi de system and NO system of the heart when compared with control group. Conclusions: Angiolin does not infl uence directly on NOS in MI, but at the same time protects NO from nitrosative stress increasing restored equivalents of thioldisulfi de system.
ABSTRACT
Background: Acute ischemic stroke is a leading cause of mortality, morbidity, long-term disability in industrialized countries. One of main parts of it pathogenesis is production of reactive oxygen species. The accumulation of them in neurons results in lipid peroxidation, protein oxidation, DNA damage, and finally cell death. Thereby the search of novel drugs, that have antioxidant action and can be used to complex treatment of cerebral strokes is reasonable. It is known, that xanthine derivatives exhibit a broad spectrum of biological activity, including antioxidant. So that, the goal of this research was to study in vivo neuroprotective action of water-soluble derivative of 3-benzylxanthine – morpholin-4-ium 3-benzylxanthinyl-8-methylthioacetate (Ale-15 compound) in comparison with neuroprotector-antioxidant – Mexidol. Methods: Experimental part was done on white Wistar rats of both sexes of 220-260 g weight. For assessment of neuroprotective action of compound we used a model of global incomplete cerebral ischemia, that was reproduced by bilateral common carotid arteries ligation. Results: It was studied an acute toxicity of Ale-15 compound, it influence on survival of laboratory animals, on progression of neuralgic deficit, on the content of adenylic nucleotides, on criteria of energy metabolism, on the activity of antioxidant enzymes and on oxidative modification of protein. Results of study showed, that injection of Ale-15 compound to animals with ischemic stroke intragastrically during 4 days positively reduced death rate and quantity of animals with serious neurologic symptoms. The main parts of Ale-15 cerebroprotective mechanism are antioxidant and anti-ischemic actions. Conclusions: The performed study revealed significant cerebroprotective features of Ale-15 compound in conditions of experimental cerebrovascular accident.